Editorial
High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis
Luis Ulloa,
Franak M. Batliwalla,
Ulf Andersson,
Peter K. Gregersen,
Kevin J. Tracey,
Luis Ulloa
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorFranak M. Batliwalla
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorUlf Andersson
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorPeter K. Gregersen
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorCorresponding Author
Kevin J. Tracey
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
North Shore University Hospital–Long Island Jewish Research Institute, 350 Community Drive, Manhasset, NY 11030Search for more papers by this authorLuis Ulloa,
Franak M. Batliwalla,
Ulf Andersson,
Peter K. Gregersen,
Kevin J. Tracey,
Luis Ulloa
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorFranak M. Batliwalla
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorUlf Andersson
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorPeter K. Gregersen
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
Search for more papers by this authorCorresponding Author
Kevin J. Tracey
North Shore University Hospital–Long Island Jewish Research Institute, Manhasset, New York
North Shore University Hospital–Long Island Jewish Research Institute, 350 Community Drive, Manhasset, NY 11030Search for more papers by this author
REFERENCES
- 1 Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565–70.
- 2 Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001; 164: 1768–73.
- 3 Yang H, Wang H, Tracey KJ. HMG-1 rediscovered as a cytokine. Shock 2001; 15: 247–53.
- 4 Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248–51.
- 5 Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003; 48: 971–81.
- 6 Goodwin GH, Johns EW. Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids. Eur J Biochem 1973; 40: 215–9.
- 7 Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 1973; 38: 14–9.
- 8 Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 2001; 26: 152–3.
- 9 Bianchi ME, Beltrame M. Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep 2000; 1: 109–14.
- 10 Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S, et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 1999; 22: 276–80.
- 11 Merenmies J, Pihlaskari R, Laitinen J, Wartiovaara J, Rauvala H. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth: amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991; 266: 16722–9.
- 12 Sajithlal G, Huttunen H, Rauvala H, Munch G. Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells. J Biol Chem 2002; 277: 6888–97.
- 13 Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000; 405: 354–60.
- 14 Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001; 152: 1197–206.
- 15 Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002; 3: 995–1001.
- 16 Yang H, Wang H, Erlandsson-Harris H, Moldawer LL, Czura CJ, Ulloa L, et al. Rescue from lethal sepsis by inhibiting HMGB-1. Submitted for publication.
- 17 Abraham E, Arcaroli J, Carmody A, Wang HC, Tracey KJ. Cutting edge: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165: 2950–4.
- 18 Agnello D, Wang H, Yang H, Tracey KJ, Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002; 18: 231–6.
- 19 Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 2002; 99: 12351–6.
- 20 Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1 (HMGB1). Mol Med. In press.
- 21 Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191–5.
- 22 Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL, Fink MP. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002; 123: 790–802.
- 23 Ombrellino M, Wang H, Ajemian MS, Talhouk A, Scher LA, Friedman SG, et al. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 1999; 354: 1446–7.
- 24 Kokkola R, Sundberg E, Ulfgren A-K, Palmblad K, Li J, Wang H, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002; 46: 2598–603.
- 25 Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin: enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 1991; 266: 16730–5.
- 26 Rouhiainen A, Imai S, Rauvala H, Parkkinen J. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost 2000; 84: 1087–94.
- 27 Ayer LM, Senecal JL, Martin L, Dixon GH, Fritzler MJ. Antibodies to high mobility group proteins in systemic sclerosis. J Rheumatol 1994; 21: 2071–5.
- 28 Rosenberg AM, Cordeiro DM. Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis. J Rheumatol 2000; 27: 2489–93.
- 29 Sobajima J, Ozaki S, Uesugi H, Osakada F, Shirakawa H, Yoshida M, et al. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin Exp Immunol 1998; 111: 402–7.
- 30 Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170–6.
